Scientists at Sweden’s Karolinska Institutet have managed to build a fully functional neuron by using organic bioelectronics. This artificial neuron contain no ‘living’ parts, but is capable of mimicking the function of a human nerve cell and communicate in the same way as our own neurons do.
Neurons are isolated from each other and communicate with the help of chemical signals, commonly called neurotransmitters or signal substances. Inside a neuron, these chemical signals are converted to an electrical action potential, which travels along the axon of the neuron until it reaches the end. Here at the synapse, the electrical signal is converted to the release of chemical signals, which via diffusion can relay the signal to the next nerve cell.
To date, the primary technique for neuronal stimulation in human cells is based on electrical stimulation. However, scientists at the Swedish Medical Nanoscience Centre (SMNC) at Karolinska Institutet in collaboration with collegues at Linköping University, have now created an organic bioelectronic device that is capable of receiving chemical signals, which it can then relay to human cells.
“Our artificial neuron is made of conductive polymers and it functions like a human neuron”, says lead investigator Agneta Richter-Dahlfors, professor of cellular microbiology. “The sensing component of the artificial neuron senses a change in chemical signals in one dish, and translates this into an electrical signal. This electrical signal is next translated into the release of the neurotransmitter acetylcholine in a second dish, whose effect on living human cells can be monitored.“
The research team hope that their innovation, presented in the journal Biosensors & Bioelectronics , will improve treatments for neurologial disorders which currently rely on traditional electrical stimulation. The new technique makes it possible to stimulate neurons based on specific chemical signals received from different parts of the body. In the future, this may help physicians to bypass damaged nerve cells and restore neural function.
“Next, we would like to miniaturize this device to enable implantation into the human body”, says Agneta Richer-Dahlfors. “We foresee that in the future, by adding the concept of wireless communication, the biosensor could be placed in one part of the body, and trigger release of neurotransmitters at distant locations. Using such auto-regulated sensing and delivery, or possibly a remote control, new and exciting opportunities for future research and treatment of neurological disorders can be envisaged.”
This study was made possible by funding from Carl Bennet AB, VINNOVA, Karolinska Institutet, the Swedish Research Council, Swedish Brain Power, Knut and Alice Wallenberg Foundation, the Royal Swedish Academy of Sciences, and Önnesjö Foundation.
View a movie about the findings
Publication: ‘An organic electronic biomimetic neuron enables auto-regulated neuromodulation’, Daniel T. Simon, Karin C. Larsson, David Nilsson, Gustav Burström, Dagmar Galter, Magnus Berggren, Agneta Richter-Dahlfors, Biosensors & Bioelectronics , first online 22 April 2015, Volume 71 , 15 September 2015, Pages 359–364.
For more information, please contact:
Agneta Richter-Dahlfors , PhD, Professor
Lead investigator, Swedish Medical Nanoscience Centre
Department of Neuroscience, Karolinska Institutet
Tel: +46 (0)8 524 874 25
Email: [email protected]
Ben Libberton, PhD, Postdoc
Public information officer, Swedish Medical Nanoscience Centre
Department of Neuroscience, Karolinska Institutet
Tel: +46 (0)737259236
Email: [email protected]
To date, the primary technique for neuronal stimulation in human cells is based on electrical stimulation. However, scientists at the Swedish Medical Nanoscience Centre (SMNC) at Karolinska Institutet in collaboration with collegues at Linköping University, have now created an organic bioelectronic device that is capable of receiving chemical signals, which it can then relay to human cells.
“Our artificial neuron is made of conductive polymers and it functions like a human neuron”, says lead investigator Agneta Richter-Dahlfors, professor of cellular microbiology. “The sensing component of the artificial neuron senses a change in chemical signals in one dish, and translates this into an electrical signal. This electrical signal is next translated into the release of the neurotransmitter acetylcholine in a second dish, whose effect on living human cells can be monitored.“
The research team hope that their innovation, presented in the journal Biosensors & Bioelectronics , will improve treatments for neurologial disorders which currently rely on traditional electrical stimulation. The new technique makes it possible to stimulate neurons based on specific chemical signals received from different parts of the body. In the future, this may help physicians to bypass damaged nerve cells and restore neural function.
“Next, we would like to miniaturize this device to enable implantation into the human body”, says Agneta Richer-Dahlfors. “We foresee that in the future, by adding the concept of wireless communication, the biosensor could be placed in one part of the body, and trigger release of neurotransmitters at distant locations. Using such auto-regulated sensing and delivery, or possibly a remote control, new and exciting opportunities for future research and treatment of neurological disorders can be envisaged.”
This study was made possible by funding from Carl Bennet AB, VINNOVA, Karolinska Institutet, the Swedish Research Council, Swedish Brain Power, Knut and Alice Wallenberg Foundation, the Royal Swedish Academy of Sciences, and Önnesjö Foundation.
View a movie about the findings
Publication: ‘An organic electronic biomimetic neuron enables auto-regulated neuromodulation’, Daniel T. Simon, Karin C. Larsson, David Nilsson, Gustav Burström, Dagmar Galter, Magnus Berggren, Agneta Richter-Dahlfors, Biosensors & Bioelectronics , first online 22 April 2015, Volume 71 , 15 September 2015, Pages 359–364.
For more information, please contact:
Agneta Richter-Dahlfors , PhD, Professor
Lead investigator, Swedish Medical Nanoscience Centre
Department of Neuroscience, Karolinska Institutet
Tel: +46 (0)8 524 874 25
Email: [email protected]
Ben Libberton, PhD, Postdoc
Public information officer, Swedish Medical Nanoscience Centre
Department of Neuroscience, Karolinska Institutet
Tel: +46 (0)737259236
Email: [email protected]
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
